missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Uroplakin Ib, Mouse anti-Human, Clone: UPK1B/3273, Novus Biologicals™
  7. 18212077

Uroplakin Ib, Mouse anti-Human, Clone: UPK1B/3273, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-79801-100UG

 View more versions of this product

Product Code. 18212077

  • £377.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Uroplakin Ib Monoclonal specifically detects Uroplakin Ib in Human samples. It is validated for ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Protein Array.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Uroplakin Ib
Monoclonal
0.2 mg/mL
ELISA, Immunohistochemistry 1-2 ug/ml, Immunohistochemistry-Paraffin 1-2 ug/ml, Protein Array
tetraspanin-20, Tspan-20, TSPAN20tetraspan, UP1b, UPIb, UPK1, uroplakin 1B, Uroplakin Ib, uroplakin-1b
Mouse
Protein A or G purified
RUO
7348
Store at 4°C.
IgG1 κ
ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin), Peptide Array
UPK1B/3273
Unconjugated
10 mM PBS with 0.05% BSA
UPK1B
Recombinant fragment (around aa 109-229) of human Uroplakin Ib protein (exact sequence is proprietary)
100 μg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.